---
document_datetime: 2023-09-21 20:18:07
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/qutavina-epar-all-authorised-presentations_en.pdf
document_name: qutavina-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7914845
conversion_datetime: 2025-12-19 05:58:12.205089
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength    | Pharmaceutical Form    | Route of Administration   | Immediate Packaging                   | Content (concentration)   | Pack size         |
|------------------|-------------------|-------------|------------------------|---------------------------|---------------------------------------|---------------------------|-------------------|
| EU/1/20/1463/001 | QUTAVINA          | 20 µg/80 µl | Solution for injection | Subcutaneous use          | cartridge (glass) in a pre-filled pen | 2.7 ml                    | 1 pre-filled pen  |
| EU/1/20/1463/002 | QUTAVINA          | 20 µg/80 µl | Solution for injection | Subcutaneous use          | cartridge (glass) in a pre-filled     | 2.7 ml                    | 3 pre-filled pens |

<!-- image -->